12:00 AM
 | 
May 03, 1999
 |  BC Week In Review  |  Clinical News  |  Regulatory

Boehringer Ingelheim Pharmaceuticals Inc. regulatory update

The FDA's Peripheral & Central Nervous System Drugs Advisory Committee voted unanimously to recommend...

Read the full 47 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >